Tag Archives: biopharmaceutical

Hotspots in Biopharma Digital Marketing Innovation

The rapid growth of digital, mobile and related technologies has transformed the global communications paradigm, and with it, changed the ways in which consumers and professionals access information. In case of the biopharmaceutical and medical device industry, the development of

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

New Study Published: Advisory Board Management at Large Pharma & Device Companies

Best Practices, LLC just published a new research report on Advisory Board Management. The report examines how Advisory Boards at large, mid-cap, and small companies are able to organize, recruit and plan such critical product shaping think tanks. An effective

Patient Centricity Has Arrived. Bigger Question: Where Is It Headed?

Patients have always been on pharma’s radar, though it has historically been as a target of marketing (the most obvious being Direct to Consumer (DTC) advertising).  But now under the banner of Patient Centricity, pharma companies large and small are

Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

Thou Shalt Build Credibility But Plan for the Worst

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and

Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Success Factors & Lessons Learned in New Product Launches

In today’s competitive & crowded marketplace, biopharmaceutical companies are investing more and more resources to develop and launch new products for cardiovascular therapeutic areas. Consequently, recent industry product launches have produced both noteworthy failures and successes. It is now, more

Optimizing Government Affairs & Public Policy Groups’ Structures & Operations

Public Policy and Government Affairs functions within the pharmaceutical industry have become increasingly critical during this period of political, economic, and social turbulence. With both functions involved in essential areas such as legislative affairs, reimbursement, and regulatory, it’s important for

SPECIAL: Highlights from Medical Affairs Consortium 3rd Roundtable

The Medical Affairs function is constantly changing & leaders are being presented with various obstacles and hurdles they must overcome. One of the key areas that leaders have been struggling with recently is effective thought leader management. In order to

New Technologies Creating New Public Relations Opportunities

While marketers in the biopharmaceutical industry have long used Public Relations as a tool to support their brands, recent technologies –social networks, audio sharing, and video sharing—are creating fertile new ground for PR experts. These new additions to the Public